Cell Banking Outsourcing Market

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Cell Banking Outsourcing Market contains market size and forecasts of Cell Banking Outsourcing in Global, including the following market information:
Global Cell Banking Outsourcing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Banking Outsourcing market was valued at 7049.4 million in 2021 and is projected to reach US$ 20370 million by 2028, at a CAGR of 16.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Banking Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Banking Outsourcing include SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec and CordLife, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Banking Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Banking Outsourcing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Banking Outsourcing Market Segment Percentages, by Type, 2021 (%)
Stem Cell Banking
Non-stem Cell Banking
Global Cell Banking Outsourcing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell Banking Outsourcing Market Segment Percentages, by Application, 2021 (%)
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation
Global Cell Banking Outsourcing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell Banking Outsourcing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Banking Outsourcing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Banking Outsourcing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell